VION Biosciences is positioned to be a best-in-class life science platform delivering market-leading manufacturing and mission-critical chemicals and specialty reagents alongside value-added services to enable scientific discovery, clinical testing, therapeutic development, and innovative solutions across a wide platform of key applications in the biochemical and life science sectors, from research to commercialization.
Investors 1
| Date | Name | Website |
| 08.06.2026 | BPEA Priva... | bpea-pe.co... |
Mentions in press and media 2
| Date | Title | Description |
| 30.08.2024 | Ascension Advisory Facilitates Sale Leaseback of Ansh Labs Facility Alongside Acquisition by VION Biosciences | Ascension Advisory Logo Ansh Labs This was a great transaction all around. Our client realized attractive economics from the sale leaseback transaction while ensuring long-term operational continuity for the business.” — Chelsea Mandel, Fou... |
| 22.08.2024 | VION Biosciences Acquires Echelon Biosciences | Vion Biosciences, a Charlottesville, VA-based life science platform company focused on specialty reagents in the life science research, diagnostic, and drug discovery space, acquired Echelon Biosciences, a Salt Lake City, UT-based supplier ... |